The Company is a newly established investing company incorporated on 2020-06-11 in England and Wales. The Company will invest in early and later-stage Life Sciences businesses. Investments are expected to be mainly in the form of equity and equity-related instruments, including convertible debt instruments in certain circumstances. The Company's strategy is to invest in unquoted companies, however it may also invest in companies whose shares are publicly traded. The Company may acquire investments directly or by way of holdings in intermediate holding or subsidiary entities. The Company might also invest in limited liability partnerships and other forms of legal entity.